Related Experiment Video
Updated: Apr 5, 2026

04:08
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
Published on: June 27, 2025
1.3K
Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta
1University of Utah School of Medicine, Salt Lake City, Utah.
Obstetrics and Gynecology
|August 6, 2015
Summary
Placental disorders like placenta previa, accreta, and vasa previa cause significant maternal and fetal risks. Antenatal diagnosis via ultrasonography improves management of these increasingly common pregnancy complications.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Diagnostic Imaging
Background:
- Placental disorders including placenta previa, placenta accreta, and vasa previa are linked to second-trimester vaginal bleeding.
- These conditions are significant contributors to maternal and fetal morbidity and mortality.
- Increasing rates of cesarean delivery, advanced maternal age, and assisted reproductive technologies are associated with rising incidences of placenta previa and accreta.
Purpose of the Study:
- To review the clinical management of pregnancies complicated by placenta previa, placenta accreta, and vasa previa.
- To emphasize an evidence-based approach to managing these conditions.
- To identify knowledge gaps in the management of these placental disorders.
Main Methods:
- Review of current literature on placental disorders.
- Emphasis on evidence-based clinical management strategies.
- Discussion of the role of ultrasonography in antenatal diagnosis.
Main Results:
- Ultrasonography enables antenatal diagnosis of placenta previa, accreta, and vasa previa.
- Antenatal diagnosis is crucial for optimizing obstetric management.
- Increasing rates of these disorders necessitate improved management strategies.
Conclusions:
- Effective management of placental disorders relies on accurate antenatal diagnosis.
- An evidence-based approach is essential for improving outcomes in pregnancies with these conditions.
- Further research is needed to address existing knowledge gaps in managing placental disorders.
Related Concept Videos
Fetal Circulation
4.7K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
4.7K
Development of Blood Vessels
1.9K
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
1.9K
Abnormal Proliferation
3.8K
3.8K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Teratogenicity
4.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Uterus and Cervix
7.4K
The uterus, commonly called the womb, is a vital reproductive organ in females designed to provide a nurturing environment for the implantation and growth of an embryo. It is shaped like a hollow pear and positioned between the urinary bladder and the rectum. The uterus's structure allows it to support and protect a developing fetus throughout pregnancy.
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs...
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs...
7.4K

